BR9709930A - Compound pharmaceutical composition use of a compound and processes for treating a human or animal individual and for preparing a compound - Google Patents
Compound pharmaceutical composition use of a compound and processes for treating a human or animal individual and for preparing a compoundInfo
- Publication number
- BR9709930A BR9709930A BR9709930A BR9709930A BR9709930A BR 9709930 A BR9709930 A BR 9709930A BR 9709930 A BR9709930 A BR 9709930A BR 9709930 A BR9709930 A BR 9709930A BR 9709930 A BR9709930 A BR 9709930A
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- treating
- preparing
- human
- processes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9613017.4A GB9613017D0 (en) | 1996-06-21 | 1996-06-21 | Therapeutic compounds |
| GBGB9613095.0A GB9613095D0 (en) | 1996-06-21 | 1996-06-21 | Therapeutic piperidines |
| GBGB9613018.2A GB9613018D0 (en) | 1996-06-21 | 1996-06-21 | Therapeutic indazoles |
| PCT/EP1997/003196 WO1997049699A1 (en) | 1996-06-21 | 1997-06-19 | Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9709930A true BR9709930A (en) | 1999-08-10 |
Family
ID=27268341
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9709930A BR9709930A (en) | 1996-06-21 | 1997-06-19 | Compound pharmaceutical composition use of a compound and processes for treating a human or animal individual and for preparing a compound |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0912555A1 (en) |
| JP (1) | JP2000512648A (en) |
| KR (1) | KR20000022041A (en) |
| AP (1) | AP9801417A0 (en) |
| AR (1) | AR008245A1 (en) |
| AU (1) | AU3261197A (en) |
| BR (1) | BR9709930A (en) |
| CA (1) | CA2258753A1 (en) |
| CZ (1) | CZ424698A3 (en) |
| EA (1) | EA199801015A1 (en) |
| ID (1) | ID17052A (en) |
| IL (1) | IL127464A0 (en) |
| IS (1) | IS4924A (en) |
| NO (1) | NO985974L (en) |
| PL (1) | PL330797A1 (en) |
| TR (1) | TR199802665T2 (en) |
| WO (1) | WO1997049699A1 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7642278B2 (en) | 2001-07-03 | 2010-01-05 | Novartis Vaccines And Diagnostics, Inc. | Indazole benzimidazole compounds |
| US7064215B2 (en) | 2001-07-03 | 2006-06-20 | Chiron Corporation | Indazole benzimidazole compounds |
| TW200401641A (en) | 2002-07-18 | 2004-02-01 | Wyeth Corp | 1-Heterocyclylalkyl-3-sulfonylindole or-indazole derivatives as 5-hydroxytryptamine-6 ligands |
| MXPA05008438A (en) * | 2003-02-14 | 2005-10-19 | Wyeth Corp | Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands. |
| WO2007117413A1 (en) | 2006-04-05 | 2007-10-18 | Wyeth | Sulfonyl-3-heterocyclylindazole derivatives as 5-hydroxytryptamine-6 ligands |
| MX2009007416A (en) | 2007-01-10 | 2009-07-17 | Hoffmann La Roche | Sulfonamide derivatives as chymase inhibitors. |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4124942A1 (en) * | 1991-07-27 | 1993-01-28 | Thomae Gmbh Dr K | 5-LOW HETEROCYCLES, METHOD FOR THE PRODUCTION THEREOF AND MEDICAMENTS CONTAINING SUCH COMPOUNDS |
| JPH07501063A (en) * | 1991-11-14 | 1995-02-02 | グラクソ、グループ、リミテッド | Piperidine acetic acid derivatives as fibrinogen-dependent platelet aggregation inhibitors |
| GB9208740D0 (en) * | 1992-04-23 | 1992-06-10 | Glaxo Group Ltd | Chemical compounds |
-
1997
- 1997-06-18 AR ARP970102676A patent/AR008245A1/en unknown
- 1997-06-19 EP EP97928243A patent/EP0912555A1/en not_active Withdrawn
- 1997-06-19 AU AU32611/97A patent/AU3261197A/en not_active Abandoned
- 1997-06-19 EA EA199801015A patent/EA199801015A1/en unknown
- 1997-06-19 ID IDP972092A patent/ID17052A/en unknown
- 1997-06-19 KR KR1019980710439A patent/KR20000022041A/en not_active Application Discontinuation
- 1997-06-19 JP JP10502284A patent/JP2000512648A/en active Pending
- 1997-06-19 AP APAP/P/1998/001417A patent/AP9801417A0/en unknown
- 1997-06-19 PL PL97330797A patent/PL330797A1/en unknown
- 1997-06-19 IL IL12746497A patent/IL127464A0/en unknown
- 1997-06-19 WO PCT/EP1997/003196 patent/WO1997049699A1/en not_active Application Discontinuation
- 1997-06-19 BR BR9709930A patent/BR9709930A/en not_active Application Discontinuation
- 1997-06-19 TR TR1998/02665T patent/TR199802665T2/en unknown
- 1997-06-19 CZ CZ984246A patent/CZ424698A3/en unknown
- 1997-06-19 CA CA002258753A patent/CA2258753A1/en not_active Abandoned
-
1998
- 1998-12-15 IS IS4924A patent/IS4924A/en unknown
- 1998-12-18 NO NO985974A patent/NO985974L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2258753A1 (en) | 1997-12-31 |
| WO1997049699A1 (en) | 1997-12-31 |
| IS4924A (en) | 1998-12-15 |
| JP2000512648A (en) | 2000-09-26 |
| NO985974D0 (en) | 1998-12-18 |
| AR008245A1 (en) | 1999-12-29 |
| ID17052A (en) | 1997-12-04 |
| KR20000022041A (en) | 2000-04-25 |
| EA199801015A1 (en) | 1999-08-26 |
| CZ424698A3 (en) | 1999-05-12 |
| AU3261197A (en) | 1998-01-14 |
| EP0912555A1 (en) | 1999-05-06 |
| TR199802665T2 (en) | 1999-03-22 |
| AP9801417A0 (en) | 1998-12-31 |
| IL127464A0 (en) | 1999-10-28 |
| NO985974L (en) | 1999-02-17 |
| PL330797A1 (en) | 1999-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9610248A (en) | Compound pharmaceutical composition processes for the treatment of pain and for the preparation of a compound and use of the compound | |
| BR9710359A (en) | Compound pharmaceutical formulation use of a compound and processes for the preparation of a compound and for treatment of a human or animal individual suffering from a disorder mediated by aberrant protein tyrosine kinase activity | |
| BR9612204A (en) | Compound use of the compound Pharmaceutical composition and process for preparing the compound and for treating pain | |
| BR9702147A (en) | Pharmaceutical composition use of a pharmaceutical composition and process for the treatment of pain associated with periodontal scarification and for the preparation of a pharmaceutical composition | |
| BR9100435A (en) | COMPOUND, PHARMACEUTICAL COMPOSITION, USE, METHOD OF TREATING AN ANIMAL, PROCESSES FOR THE PREPARATION OF A COMPOUND AND PHARMACEUTICAL COMPOSITION | |
| BR9507656A (en) | Compound use of a compound Pharmaceutical composition and processes for the treatment of a patient suffering from pain and for the preparation of a compound | |
| BR9602933A (en) | Compound processes for preparation of compost and pharmaceutical composition and compost | |
| BR9609467A (en) | Compound use of a compound Pharmaceutical composition and processes for preparing a compound and treating plank aggregation disorders | |
| BR9612309A (en) | Compound use of a compound pharmaceutical composition aerosol combination pharmaceutical formulation and processes for the treatment of a human or animal individual with an anti-inflammatory and / or allergic condition and for the preparation of a compound | |
| BR9603919A (en) | Antiparasitic composition for the treatment and protection of pets | |
| BR9709915A (en) | Compound pharmaceutical composition use of the compound and processes for the treatment or prevention of physiological disorders associated with an excess of tachykinins and for the preparation of the compound | |
| BR9503812A (en) | Compound pharmaceutical composition use method of treatment of a human process for the preparation of a compound | |
| BR9604872A (en) | Composition for hair treatment | |
| BR9609532A (en) | Antimicrobial composition for the treatment of hair process for the treatment of dandruff and use of the composition | |
| DE69710095D1 (en) | PHARMACEUTICAL PREPARATION FOR TREATING DIABETES | |
| PT955995E (en) | USING COMPLEXES FOR THE PREPARATION OF TREATMENT COMPOSITIONS FOR SENSITIVE SKINS, PREPARATION PROCESS AND HYPOALERGENIC COMPOUNDS | |
| BR9711311A (en) | Compound pharmaceutical composition use of a compound and processes for the preparation of compounds and for the treatment of a mammal including man | |
| BR9505610A (en) | Compound pharmaceutical composition process for the preparation of a compound use and method of treating inflammation and pain | |
| FI962908A (en) | Antimicrobial composition, method of its preparation and its use | |
| BR9502471A (en) | Guanidine compound Process for preparing a guanidine compound Pharmaceutical composition Use of a guanidine compound Method for the prophylactic or therapeutic treatment of diseases and process for preparing a pharmaceutical composition | |
| BR9708607A (en) | Compound pharmaceutical composition use of a compound process for treating or reducing the risk of inflammatory disease in a patient and for the preparation of a compound and chemical intermediate | |
| BR9710376A (en) | Antiviral compound use of the same pharmaceutical composition and process for prophylactic or therapeutic antiviral treatment of a human or non-human animal | |
| EE9800234A (en) | Method of treatment and pharmaceutical composition | |
| BR9610733A (en) | Compound processes for the preparation of it and for the treatment of a mammal pharmaceutical composition and use of a compound | |
| BR9711225A (en) | Transdermal propentophylline compositions for the treatment of alzheimer's disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |